NOVABIO Research Profile

What Is Glutathione (GSH)?

Glutathione (GSH) is a tripeptide-derived compound widely recognized in redox and antioxidant-pathway research. This page identifies the material as Glutathione (GSH), with amino acid count 3; physical form Lyophilized powder. The Glutathione (GSH) identifiers distinguish this catalogue entry from similarly named compounds, fragments, modified analogues, and multi-component formulations. Identity fields describe the named catalogue record and must not be generalized to a different salt, counter-ion, hydrate or formulation.

Exact-product regulatory reviewLast verified 2026-10-06
Catalogue identityGlutathione (GSH)
Available specifications400mg, 600mg, 1500mg
Evidence snapshot1163 trials · 206798 publications
Last verified2026-10-06

What Is Glutathione (GSH)?

Glutathione (GSH) is a tripeptide-derived compound widely recognized in redox and antioxidant-pathway research. This page identifies the material as Glutathione (GSH), with amino acid count 3; physical form Lyophilized powder. The Glutathione (GSH) identifiers distinguish this catalogue entry from similarly named compounds, fragments, modified analogues, and multi-component formulations.

Identity fields describe the named catalogue record and must not be generalized to a different salt, counter-ion, hydrate or formulation.

Evidence at a Glance

1163ClinicalTrials.gov query records
206798PubMed query records
6Selected publications shown

Sources: ClinicalTrials.gov query · PubMed query · Retrieved 2026-10-06

Mechanism & Pharmacology

The research record for Glutathione (GSH) is organized around redox-biology studies, thiol chemistry, oxidative-pathway research, and analytical compound characterization. For Glutathione (GSH), those subjects define the literature and analytical context of this specific research compound; they do not establish a clinical indication, administration route, or expected outcome.

Mechanistic or pathway language defines a research scope. It does not establish that a catalogue product produces a clinical effect.

Clinical Development

Selected exact-query registry records are shown below. Desktop displays up to six; mobile displays up to three.

NCT ID / StudyPhaseStatusContextLast registry update
NCT00319007Influence of Sulindac and Probiotics on the Development of Pouch Adenomas in Patients With Familial Adenomatous PolyposisPhase 2UnknownAdenomatous Polyposis Coli2007-08-10
NCT02578329An Intervention Study to Assess the Effect of the Mediterranean Diet on the Plasma Fatty Acid ProfileNAUnknownCoronary Artery Disease2016-06-07
NCT01725412Prevention of Renal Complications of Diabetes With ThiaminePhase 4UnknownDiabetic Nephropathy2012-11-12
NCT01880372The Use of Alpha Lipoic Acid for the Treatment and Prevention of Diabetic RetinopathyNATerminatedModerate Non-proliferative Diabetic Retinopathy2019-02-15
NCT07724067GLUT-F Improves MASLD Liver FunctionNACompletedMASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)2026-07-23
NCT00327288Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer PatientsPhase 1CompletedNon-small Cell Lung Cancer, Breast Cancer, Prostate Cancer2015-06-24

Source: ClinicalTrials.gov search · Retrieved 2026-10-06

Selected Literature6 important records shown

Selected Literature

Selected PubMed record

The antioxidant glutathione.

Vitamins and hormones · 2023

PMID 36707132
Selected PubMed record

The Glutathione Theory of Aging.

Alternative therapies in health and medicine · 2024 Oct

PMID 39316535
Selected PubMed record

Glutathione: subcellular distribution and membrane transport (1).

Biochemistry and cell biology = Biochimie et biologie cellulaire · 2019 Jun

PMID 30427707
Selected PubMed record

Glutathione.

Annual review of biochemistry · 1983

PMID 6137189
Selected PubMed record

Versatility of Glutathione Transferase Proteins.

Biomolecules · 2023 Dec 6

PMID 38136620
Selected PubMed record

Mitochondrial Glutathione: Regulation and Functions.

Antioxidants & redox signaling · 2017 Nov 20

PMID 28558477

Source: PubMed search results · Retrieved 2026-10-06

Identity & ChemistryProduct-form fields

Identity & Chemistry

Compound / Blend
Glutathione (GSH)
Available Specifications
400mg, 600mg, 1500mg
Pack Format
10 Vials
CAS Number
70-18-8
Molecular Formula
C10H17N3O6S
Molecular Weight
307.32 g/mol
Amino Acid Count
3
Sequence
Linear tripeptide gamma-L-glutamyl-L-cysteinyl-glycine featuring an atypical gamma-peptide bond between Glu and Cys; the free cysteinyl thiol is the redox-active moiety (full sequence per COA).
Physical Form
Lyophilized powder

Identity fields describe the named catalogue record and must not be generalized to a different salt, counter-ion, hydrate or formulation.

Source: PubChem CID 124886 · Product form must still be matched to the catalogue and batch record.

Research Tools for Glutathione (GSH)

Review the selected registry records and open the module-level ClinicalTrials.gov query for the current result set.

Open Clinical Development

Use the complete NOVABIO documentation library to review currently available batch records.

Open Lab Results & COA
Storage & Laboratory HandlingDocumentation-led controls

Storage & Laboratory Handling

Confirm the exact material form, lot, supplied state and storage statement from the product label and corresponding batch documentation. Do not infer handling conditions from a different compound, strength or external clinical publication.

Regulatory Status

FDA status must be checked by exact drug product, formulation and indication; catalogue availability does not establish approval.

Source: FDA Drugs@FDA · Checked 2026-10-06

Authoritative Data Summary

Glutathione (GSH) Research Summary

Identity

Glutathione (GSH); specifications: 400mg, 600mg, 1500mg. Identity fields describe the named catalogue record and must not be generalized to a different salt, counter-ion, hydrate or formulation.

Mechanism

The research record for Glutathione (GSH) is organized around redox-biology studies, thiol chemistry, oxidative-pathway research, and analytical compound characterization. For Glutathione (GSH), those subjects define the literature and analytical context of this specific research compound; they do not establish a clinical indication, administration route, or expected outcome.

Evidence

1163 registry records and 206798 PubMed records were returned by the displayed query on 2026-10-06; counts are not quality ratings.

Regulatory context

FDA status must be checked by exact drug product, formulation and indication; catalogue availability does not establish approval.

Glutathione (GSH) is represented here by the catalogue identity Glutathione (GSH). Identity fields describe the named catalogue record and must not be generalized to a different salt, counter-ion, hydrate or formulation. The product record lists 400mg, 600mg, 1500mg as the currently available specifications. The research context is organized around this product-specific scope: The research record for Glutathione (GSH) is organized around redox-biology studies, thiol chemistry, oxidative-pathway research, and analytical compound characterization. For Glutathione (GSH), those subjects define the literature and analytical context of this specific research compound; they do not establish a clinical indication, administration route, or expected outcome. The synchronized searches returned 1163 ClinicalTrials.gov records and 206798 PubMed records for the displayed query. A registry count includes records with different designs, statuses and populations, while a publication count can include reviews, preclinical work and unrelated uses of a shared abbreviation; neither count is a quality score. For regulatory interpretation, FDA status must be checked by exact drug product, formulation and indication; catalogue availability does not establish approval. Clinical findings apply only to the studied drug product, formulation, population and protocol. NOVABIO product specifications and batch documentation are separate catalogue records and do not inherit clinical outcomes from external studies. This profile supports identity checking, source tracing and laboratory record review; it does not certify a batch, recommend treatment, provide dosing instructions or replace current official labeling and professional judgment.

Sources: PubMed · ClinicalTrials.gov · FDA · NOVABIO product record

FAQ4 evidence-bounded answers

Glutathione (GSH) FAQ

What is Glutathione (GSH)?

Glutathione (GSH) is a tripeptide-derived compound widely recognized in redox and antioxidant-pathway research. This page identifies the material as Glutathione (GSH), with amino acid count 3; physical form Lyophilized powder. The Glutathione (GSH) identifiers distinguish this catalogue entry from similarly named compounds, fragments, modified analogues, and multi-component formulations.

What research records are indexed for Glutathione (GSH)?

The synchronized query returned 1163 ClinicalTrials.gov records and 206798 PubMed records on 2026-10-06; review the linked searches because counts and record status can change.

Is Glutathione (GSH) FDA approved?

FDA status must be checked by exact drug product, formulation and indication; catalogue availability does not establish approval.

Does this page provide dosing guidance?

No. This research profile provides identity, evidence, chemistry, regulatory and documentation context without dosing or treatment instructions.

Sources, Methodology & Last Verified

Official sources
ClinicalTrials.gov, NCBI PubMed, FDA, available PubChem records, and NOVABIO product and COA records.
Query retrieved
2026-10-06T12:08:49Z
Inclusion
Exact identity terms and traceable registry, publication, chemistry, regulatory or catalogue fields.
Limitations
Search counts can include mixed evidence types and shared-name records; individual records require direct review.
Prepared by
NOVABIO Research
Reviewed date
2026-10-06
Editorial methodology
How NOVABIO builds Research Profiles
Corrections contact
Contact NOVABIO with the page URL and source record.